新闻与深度文章
新闻报道 | Novo Nordisk News Center
Novo Nordisk and Microsoft collaborate to accelerate drug discovery and development using big data and artificial intelligence
Novo Nordisk and Microsoft have entered a new strategic collaboration to combine Microsoft’s computational services, cloud and artificial intelligence (AI) with Novo Nordisk’s drug discovery, development and data science capabilities.
At UCB, our aim is to amplify the power of scientific innovation through digital transformation, ensuring we deliver the best individual experience so patients can live their best lives. As part of that effort, we are integrating artificial intelligence (AI)…
新闻报道 | Microsoft Transform
Novartis empowers scientists with AI to speed the discovery and development of breakthrough medicines
Here’s a cooking story unlike any you’ve heard before. That’s because the chefs are chemists, the ingredients are molecules, and the main course is a new medication designed to defeat illness. At least, that’s Luca Finelli’s snackable description to explain…
新闻报道 | Novartis
The art of drug design in a technological age
Novartis is collaborating with Microsoft to apply machine learning to medicinal chemistry — part of an effort to leverage AI to bring treatments to patients more efficiently. There’s a misconception about drug hunting that can mask one of the biggest…
UCB and Microsoft have announced a new multi-year, strategic collaboration to combine Microsoft’s computational services, cloud, and artificial intelligence (AI) with UCB’s drug discovery and development capabilities. As several drug discovery activities require the analysis of high-dimensional data sets or…
新闻报道 | Microsoft News
Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence
Novartis today announced an important step in reimagining medicine by founding the Novartis AI innovation lab and by selecting Microsoft Corp. as its strategic AI and data-science partner for this effort.